Why is Hypercoagulability Common in Cancer Patients?
Cancer patients often experience hypercoagulability due to the production of pro-coagulant factors by cancer cells, such as tissue factor and cancer procoagulant. Additionally, inflammatory cytokines released by both the tumor and the body's immune response can activate the coagulation cascade. Treatments like chemotherapy and surgery further elevate the risk by damaging blood vessels and reducing mobility.
